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Methods: The assay is based on the ability of viable mycobacteria to be
infected by lyric phage D29 after an overnight exposure to rifampicin. Any
phage outside the bacilli are chemically inactivated by ferrous ammonium
sulphate, while those inside are protected and replicate within the cells,
causing their lysis and the release of a new phage progeny. The phages are
detected by the formation of plaques in a lawn of the fast-grower M.
smegmatis after a 24 h incubation at 37°C. Results are available with a total
turnaround time of 48 h. The phage assay was evaluated testing 19 MTB
clinical isolates: 5 rifampicin-resistant isolates (also resistant to isoniazid) and
14 rifampicin-sensitive strains (l resistant to isoniazid and streptomycin,S
resistant to isoniazid and 8 sensitive strains). The results were compared to
the BACTEC 12B susceptibility testing method.
Results: The phage assay presented a reliable agreement level in comparison
to BACTEC 12B technique. Only one discordant result was found: 1 isolate
resistant to rifampicin and isoniazid according to BACTEC 12B was found
susceptible by the phage method. This discrepant result was confirmed after
repeated testing by the phage methodology.
Conclusions: A high correlation has been found between the phage techni-
que and the gold standard method. This simple low-cost methodology is
suitable for microbiology laboratories with limited resources, such as those
in developing COWltries.
IWeP140ISynergy between Colimicin (C) and Rifampin (R)
and between Meropenem (M) and Trovafloxacin (T) on
Adnetobacterbaumanii
E.]. Giamarellos-Bourboulis, P. Grecka, H. Giamarellou
4th Dept Internal Medicine, Athens Medical School, Athens, Greece
Objective: The incidence ofnosocomial infections by A. baumanii led to the
study of various interactions.
Methods: A 5 x 106 CFU{ml inoculum of 36 isolates resistant to 3rd
generation cephalosporins, amikacin, ciprofloxacin and R (MIC > 4I1g{ml)
and susceptible to C was over-time exposed to the interaction of 1x or 4 x
MIC of C and to 2 I1g{ml of R ie equal to its mean serum level. Thirteen
isolates susceptible to M and T were also exposed to the interaction ofM and
Tat 1 x MIC. Any ~210g 10 decrease achieved by the interaction compared
to the most active single agent was evaluated.
Results: Synergy was found as follows (% of isolates):
activity. MICSO were aroWld 4-8I1g{ml and MIC90 were over 8-161JS{ml.
Except for CampyloblUter sp and Yersinia sp.
Conclusion: Rifaximin is a non-absorbible antimicrobial agent, able to
reach concentrations higher than 200 I1g{ml. This is 10 times greater than
the MIC observed in the studied strains. Thus, rifaximin could be considered
as an altenative antibiotic to treat diarrhea while quinolones could be
reserved to treat other more important infections. However, this treatment
would not be an option for diarrhea caused by CampyloblUrer sp and Yersinia
sp.
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IWeP142! Microbiological aspects of candidosis rational
chemotherapy
A. YU. Maslov
Perm State Medical Acadany, Perm, Russian Federation
Objectives: Optimisation of antimycotic therapy.
Methods: Candida isolates were allocated from a clinical material: vaginal
secretion using the Saburo media (broth and agar). Identification of genus
and species was made using cultural attributes (type ofmycelium, formation
ofchlamidospores), assimilation tests and biochemical activity.
Level of resistance and minimal inhibitary concentrations (MIC) of
antimycotic preparations were determined in microvariant of a serial
dilutions method. The following preparations were used: amphotericin B,
natamycin, nistatine, levorine, flucytosine, c1otrimazole, myconazole, keto-
conazole, fluconazole.
Results: The investigated sample is highly geterogenic on presence of
resistance to antimycotic preparations and level of sensitivity to each of
preparations. The most effective preparations were ftucytosine and natarny-
cin (15 and 12% of resistant strains). Resistance to other antibiotics
(amphotericin B, nistatine, levorine) was marked rather seldom, but the
average parameters of MIC were higher (6.76; 55.16; 47.8 mcg{ml). The
resistance to thiazol derivatives was met authentically more often (more than
25% of resistant strains). The correlation analysis testified the pr~ce
incomplete cross resistance of fungi to these preparations.
Conclusions: The results ofantibiograms are a basis effective and eCOllOmic:
therapy of candidosis.
Conclusions: The interactions ofC and R at concentrations ofR achieved in
vivo but inactive in vitro and to a lesser extent of M ant T express a
considerable synergy promising for application in the therapy ofnosocomial
infections.
IWeP141 IIn vtlU activity of rifaximin against
enteropathogens producing traveler's diarrhoea
]. M. Sierra, M. Navia,]. Ruiz, M. Vargas,]. Gascon,]. Vila
Institut CIInic d'Infeccions i Immunologia, IDIBAPS, Hospital Clink,
Barcelona, Spain
Objectives: The main aim ofthis study was to evaluate the in vitro activity of
rifaximin against microorganisms causing diarrhoea to travelers from
different geographical areas, in comparison with other antimicrobial agents.
Methods: The MIC was done by the agar dilution method. Eight anti-
microbial agents (ampicillin, choramphenicol, trimetoprim, nalidixic acid,
ciprofloxacin, rifampicin and rifaximin (erythromicine was also used to
Campylobacter sp) were tested against 151 enteropathogens (28 E. coli
enteroagregative (EaggEC), 40 E. coli enterotoxigenic (ETEC), 20 Shigella
sonnei, 18 Shigella flexneri, 12 Salmonella sp, 12 Campylobacter sp, 11
Aeromonas sp, 10 Yersinia sp. MIC50MIC90 and percentage of resistance
were also calculated.
Results: Most of the antimicrobial agents presented a MIC90 ofaround 128
I-'g/ml or higher, thus showing high levels of resistance. Only quinolones
remain active. With the exception of Campylobacter sp, all the strains
presented low levels of resistance to nalidixic acid (EaggEC 3'5% and
Shigella sonnei 10%), and were susceptible to ciprofloxacin, MIC90 of 0.06
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IWeP143j Antifungal susceptibility testing using cytOmetric
methods
C. Pina-Vaz"', F. Sansonetty', A. Rodrigues', Sofia Costa-de-Oliveira',
A. Salvador2, A. F. Fonseca',]. Martinez-de-Oliveira3
I Dept. ofMicrobiology; 2IPA TIMUP-Illstitute ofPathology and Molecular
Immunology; 3Dept. ofGynecology, Porto School ofMedkine, University of
Porto, Portugal
Antifungal susceptibility testing remains dependent on the enumeration of
replication-competent yeast cells with long incubation times and semiquan-
titative and subjective endpoints.
Objectives: Determine the susceptibility ofCandida spp to the most impor-
tant antifungals using probes with specific cellular affinities.
Methods: Candida strains were tested according to NCCLS M27-A proto-
col for susceptibility testing to amphotericine B (AmB; Sigma), fluconazole
(Flu; Pfizer) and S-Flucitosine (S-FC; Sigma). Two sensitive and two
resistant strains were growns to stationary growth phase. 1<1' yeast cells/ml
were incubated with AmB 2 and 8l1g{ml; Flu 8 and 641JS{ml and S-FC 4 and
32.11g/ml, at 35°C with shaking for 1 hour; the cells were centrifuged and
stained, in separate vials, with propidium iodide (PI; Sigma) - Il1g/ml for 30
min, to measure membrane lesion, FUN-l (Molecular probes) - 0.5I1M{106
cells, to evaluate metabolic disturbance and JCl (Molecular probes) - 0.25
I1M{106 cells, a marker ofintegrity ofmitochondrial potential. The suspen-
sions were analyzed by flow cytometty (FCM) and epifluorescence micro-
scopy (EFM). Viability studies were done in parallel by counting the colony-
forming units (CFU).
Results: FUN-l staining evidentiated subletal yeast changes (increase in
intensity of fluorescence using FCM-FL2 and a decrease on cylindrical
intravacuolar strucrures by EFC) on sensitive strains to Flu and S-FC:
susceptibility to AmB could only be detect by JCt staining (decrease on
FL2{FLt by FCM or a decrease ofJC aggregates by EFM). PI was unable to
stain the cells after those treatments.
Conclusions: Assessment of the effect of different drugs can be quick and
reliably determined using different fluorescent probes.
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IWeP14S1 Antifungal activity of Ibuprofen alone and in
combination with fluconazole against candida species
C. Pina_Vazl.2•3• F. Sansoneul. A. Rodriguesl, A. F. Fonseca l ,).
Martinez-de-Oliveira4, P. -A. Mirdh5
J Dept. of MicrobiologYi 2IPA TIMUP- Institute ofPathology and Molecular
Immunology; JIBMC_ Institute of Molecular and Cell Biology; 'Dept. of
Gynecology, Porto Sthool of Medicine, University ofPorto , Portugal; 5Dept. of
Gynecology/Obstetrics, Uni,'ersity Hospital, LUlld, Swedell
Objective: Determine the effect of ibuprofen, alone and in combination
with fluconazole on Calldida spp and clarify its mechanism of action
Methods: Twelve strains of Candida (10 clinical isolates and 2 ATCC type
strains) were studied. Minimal inhibitory concentration (MlC) for ibupro-
fen and fluconazole were determined according to NCClS protocol M27-
A. Interaction between ibuprofen and fluconazole was assessed by a checker-
board method. Viability counts (CFU) were done on treated and non-
treated cell suspensions. Metabolic activity was evaluated with the fluor-
escent probe FUN-l by epifluorescence microscopy. Evaluation of mem-
brane lesion was assessed with complimentary methodologies: 1) flow
cytometry of yeasts cells stained with propidium iodide (PI) 2) Assays of
K + efflux 3) Transmission electron microscopy studies on whole cells and
spheroplasts.
Results: With ibuprofen concentrations ranging from 1 to 3 mg/ml a
fungistatic activity found by MICs and significant reduction of CIVS after
FUN-1 staining. A synergistic effect betwen drugs was found on 8 of the 12
strains; for the remaining strains the association was indifferent. Fungicide
effect was achieved using 10-20 mg/ml of ibuprofen demonstrated by the
cells stained with PI and a reduction of CFU; leakage of K + and
morphologic lesions evident on electron microscopy.
Condusions: Ibuprofen shows a fungistatic effect anti-Candida in low doses,
being synergistic with fluconazole. Higher doses are fungicide due to
membrane lesion. Its anti-inflammatory and analgesic proprieties may
represent an additional advantage on candidosis treatment.
IWeP146I In-vitro activity of terbinafine against Aspergillus
species and comparison with itraconazole and amphotericin B
C. B. Moore', C. M. Walls', D. W. Denningl .2
I Hope Hospital, Salford; 2University of Manchester, United Kingdom
Objectives: To determine the in-vitro activity of terbinafine (TERB)
against 100 Aspergillus isolates comprising 60 A. fllmigatus, 13 each of A.
.f1avus and A. niger. 12 ofA. terreus and I each ofA. nidulans and A. oryzae and
to compare all isolates concurrently with itraconazole (ITZ) and amphoter-
icin B (AMB).
Methods: A microtitre method using either casitone + 2% glucose
(TERB) or RPMI medium + 2% glucose (ITZ and AMB) was used.
The RPMI method has previously been used to substantiate itraconazole
resistance in A.fumigatus and to isolates were resistant to itraconazole, 9 A.
fumigatus. Drug concentrations ranged from 0.03 to 16 mg/1. The inoculum
used was 1 x 106 conidia/ml. All tests were incubated at 37°C. MICs were
defmed using a no growth end-point at 48 hr. Minimum fungicidal
concentrations (MFCs; 99.99% kill) were also determined.
Results: For all isolates, geometric mean (GM) MIC values and ranges (in
mg/I) were: TERB 2.60 and ::;0.03- > 16, ITZ 0.56 and 0.06- > 16, AMB
0.66 and 0.125- > 16. For TERB there were differences in susceptibilities
between species, with A.fumigatus (GM 19.03 and range 2- > 16 mg/I) being
significantly less susceptible (p < 0.05) than A. jlavus (GM 0.10 mgfl), A.
tfffeus (GM 0.16 mg/I) and A. niger (0.19 mg/I). For all isolates 35% (TERB),
18% (ITZ) and 71 % (AMB) were fungicidal in the drug range tested. For
TERB, the GM MFCs for A.jlavus, A. terreus and A. niger were 0.12, 4.0 and
0.29 mgfl compared with A.fumigatus (GM MFC 32.0 mgfl).
Conduslon: TERB is highly active against non-fumigatus Aspergilli.
IWeP147I Toxicity of copper (CuS04) on candida species
A. Rodrigues!·3, C. Pina Vaz l •3, S. Costa-de-Oliveira!.3, P. A. Mardh4,J.
Martine7-de-Oliveira2, A. Freitas da Fonsecal
'Depl. Microbiology; 2Dept. Obstetrics/Gyllaecology, Porto School ofMedicine;
JIPATIMUP-Institute ofPathology and Molecular Imm'lIIology. Uni"ersityof
Porro, Porto, Porrugali 'Depr. Obsterrics/Gynaecology, Ulliversity Hospiral,
Llllld, Swedw
V:lgill:ll :lnd oral c:lndidosis are two ofthc most common clinical infections
with Candida. The growing emergence of antifungal resistance stresses the
need of alternative or complementary medications.
Objedives: To evaluate the fungistatic and fungicidal concentrations of
CuS04, estimated as the minimal inhibitory concentration (MIC) and
minimal lethal concentration (MlC) on the most commonly pathogenic
Candida species.
Methods: Fourteen clinical isolates of Candida (4 C. albicans. 3 C. para-
psi/osis, 2 C. krusei, 2 C. glabrata, 2 C. tropicalis, 1 C. guil/iermondi,) were
tested (according the NCClS protocol M 27-A for susceptibility testing) at
serial concentrations ofCuS045H20 (Sigma Aldrich), ranging from 1 to 10
mM, in RPMI 1640 medium (Sigma) and in YNB medium (Difco). The
MIC for fluconazole and amphotericin B were also determined for each
strain.
Results: MIC and MLC values for copper were found to be significantly
lower (2.5 to 5 times) with YNB medium. In RPMI medium the MIC was
2.5 mM for all tested strains. except for one strain of C. glabrata that had a
MIC of 5 mM. MIC corresponded to MlC in seven strains; MlC was 2
times higher the corresponding MIC in the remaining strains. No correla-
tion was found between MIC or MLC and the susceptibility pattern to
antifungals.
Condusions: CuS04 at concentrations commonly used in mouth rinses
showed a fungicidal effect on Candida species, either sensitive or resistant to
antifungals. Our results support the use of aqueous copper solutions in the
treatment of mucosal candidosis.
IWeP148I Additive eect between antifungals and local
anaesthetics on candida species
A. Rodrigues!.3, C. Pina Vazt.3, S. Costa-de-Oliveira'·3.). Martinezde-
de-Oliveira2• A. Freitas da Fonseca'
,Dept. Microbiology; 2Dept. Obstetrics/Gynaecology, Porto School ofMedieitJej
J1PATIMUP-Institute of Pathology and Molecular Immunology, University of
Porto, Porto, Portugal
Candida species present growing resistance to antifungals, which constitutes a
challenge for the development of complementary medications.
Objectives: To evaluate the susceptibility pattern ofCandida sp~exposed to
local anesthetics (lA) and antifungals, using ATB FUNGUS (BioMer-
ieux, Vercieux, France)
Methods: Twelve Candida strains (3 C. albicans, 2 C. krusei, 2 C. glabrata, 2
C. guilliermondii, 1 C. tropicalis, I C. parapsi/osis. 1 C. lusitama) were
inoculated in ATB FUNGUS@ galleries according manufacturer's retrac-
tions (control). For each strain additional galleries were prepared in dupli-
cate, with lA (I % and 3% oflidocaine; 0.5% ofbupivacaine) added to the
growth medium (ATB F); pH was adjusted whenever needed. After
incubation MIC for 5-flucytosine (5-FC) and amphotericin B (AMB)
were read.
Results: MIC values in presence of lA, at all tested concentrations were
lower than controls except for 1 strain of C. krusei in which no effect was
registered with 5-FC. Lidocaine showed a dose-related effect. Bupivacaine
0.5% was, in general, more potent than lidocaine 1%. The highest effect was
registered with lidocaine 3%. ATB FUNGUS@ also allows the classification
of organisms as sensitive, intermediate or resistant to nystatine, miconazole,
econazole and ketoconazole. lA showed a similar dose-related effect,
promoting the increase in sensitivity ofintermediate and resistant strains.
Condusions: Our results demonstrate the occurrence of an additive effect
between antifungals and lA, which might be wortb further detailing both in
vitro and ill vivo.
IWeP1491Susceptibility of clinical yeast isolates to
fluconazole (FCA) and 5-flucytoslne (5FO of a multinational
study
W. Fegclerl,J. Bille2, B. Dupont3, 1. B. Edebo', D. H. Ellis', R. Kappe",
A. Makristathis7,J. F. G. M. Meis8, M. RitzIer2, Gertrud Schar2, A. -F.
Schmalreck6 , Maria A. Viviani9 , Birgit Willin~er7
'IlISt. of Med. Microbiology, MUlISter, Germanr; ,Su'itzerland; J, France; 4,
Sweden; " Australia; ., Germany; 7, Austria; ,Netherlands;', Italy
To improve the early antifungal intervention therapy 1268 clinical yeast
isolates cultured in the routine diagnostic oft 0 mycological diagnostic and 2
reference laboratories were tested in a break-point-test to FCA (4; 8; 25p.g/
ml) and 5FC (1; 4; 25 jAg/ml) according to the NeCLS M27 A method.
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The most common species was C. albicans (62.1 %), whereas the propor-
tions of the other yeast species were centre dependent.
The isolates were categorised in susceptibility classes (SC) to FCA after 48
h incubation time: SC-A (MIC ~ 8 mg/l) 66.9%; SC-B (MIC > 8 ~ 25
mg/l) 8.1 %; SC-C (MIC > 25 mg/l) 24.9% and to 5FC: SC-A (MIC ~ 4
mg/l) 91.2%; SC-B (MIC > 4 ~ 25 mg/l) 4.1 % and SC-C (MIC > 25
mg/i) 4.5%. The proportions of the SC-C strains varied in the different
species and centres and for both antimycotica.
As shown by pair to pair analyses strains resistant to one antimycoticum
often were sensitive to the other, for example 77.1 % ofthe C. albicatls strains
resistant to FCA were sensitive to 5FC and 15 (65.2%) ofthe 5FC resistant C.
tropicalis strains were sensitive to FCA.
In conclusion: Each centre had its own different species and susceptibility
distribution. In an early antifungal intervention therapy a combination of
FCA and 5FC may be helpful by an extended susceptibility spectrum and
greater number of sensitive strains.
[WeP150IEvaluation of fungitest and etest for susceptibility
to amphotericin Band fluconazole on Isolates from AIDS
patients
M. D. Pinheiro', C. Gouveia!, S. Costa-de-Oliveira2, C. Pina-Vaz l.2
'Laborarorio de Microbiologia, Hospital s.)oao; 2Dept. Microbiology, School of
Medicitle, Porto, Portugal
Objedives: To evaluate susceptibilities of Catldida spp and Cryptococcus
isolates from AIDS patients to amphotericin B (AmB) and fluconazole
(Flu) using Fungitest (F) and Etest (E) compared with the broth microdilu-
tion test (BM).
Methods: In a total of 80 different biological samples from 61 AIDS
patients, 90 yeasts were isolated and identified as 79 Catldida spp. and I I
Cryptococcus tleoformatls. Isolates were studied for AmB and Flu, using F, E
and BM (employing NCCLS M27-A protocol). Yeasts were classified as
susceptible, intermediate (or susceptible-dose dependent) and resistant. The
results were divided into agreement (equal classification), major discrepancy
(susceptible by one method, resistant by another) and minor discrepancy in
other cases.
Results: The results are displayed in the following table where under F/BM
and E/BM are presented the percentage of agreement, minor and major
discrepancies for the antifungal agents studied and the different isolates.
Isolates (n) Agents F/BM% E/BM%
C. albica,JS (58) AmB 100/-/- 100/-/-
Flu 97/3/- 91/7/2 C. glab,ata (11)
AmB 100/-1- 100/-1- Flu
4614618 37154/9 C. Itrust; (10) AmB
80/20/- 20/-180 Flu 60/40/-
80/20/- C. "eoformam (11) AmB 100/-1-
100/-1- Flu 100/-1- 55/45/-
Condusions: Taken in a whole, F/MB agreement was better than E/MB,
which favors its use in routine evaluation.
IWeP151 I Insight into the DNA types and etiologic agents of
candidemia. Susceptibility to voriconazole (UK-109 496) and
other triazole derivatives
K. Kollia" E. Belesiotou2, A. iazou2, E. Plarsouki, D. Toukas', O.
Kostoula" N.]. Legakis', A. Velegrakil , A. Mitrousia', O. Paniara2
'Dept. ofMicrobiology, Mycology Referetlce Laboratory, Medical School,
Utliversity ofAthens; 2Microbiology Laboratory, District General Hospital
"Evatlgelismos", Athens, Greece
Objectives: To identify the etiologic agents ofcandidemia in a large General
Hospital. To determine susceptibility to voriconazole, compare it with other
triazole derivatives and to ascertain strain variability among bloodstream
isolates from ICU, oncology, surgical ward patients and transplant recipi-
ents.
Methods: A total of 58 isolates of Candida species were isolated from an
equal number of ICU, oncology, surgical ward and transplant recipients,
over two years. Isolates were identified by the API ID 32 system (bioMer-
ieux, Marcy I' Etoile, France). Susceptibility to itraconazole and fluconazole
was assayed by the NCClS microdilution method and voriconazole by a
modification of that method. Strains of the same species were typed by two
methods: random amplification ofpolymorphic DNA (RAPDs) and pulsed
field gel electrophoresis (PFGE) of digested chromosomes with restriction
endonucleases.
Results: C. albicatls was responsible for 56.8% of bloodstream infections in
the hospital, followed by C. ITopicalis, C.glabrata, C. parapsilosis, C.famata C.
pelliculosa, C. plllcherrima and C. pelliculosa (1.7%) and Clavispora lusitatliae
(3.4%). In the ICU 16 candidemia cases were diagnosed mainly attributable
to C. albicatls. The range of voriconazole MICs for C. glabrata strains was
0.01-0.25 J.lg/ml. Distinct clusters ofC. albicatls DNA types in the ICU and
in other ward patients.
Conclusions: C. albicatls was the main cause ofbloodstream infections in the
hospital. Fluconazole resistant Candida spp. and strains were susceptible to
voriconazole. The majority of patients were infected with Candida spp. of
the same DNA type.
IWeP1521 Disk diusion method for fluconazole susceptibility
testing of candida albicans strains
M. Yiicesoy, N. $. Giilda~, N. Yulug
Dokuz Eyliil Utliversity, School ofMdicitle, Departmetlt of Microbiology,
izmir, Turkey
Objectives: To evaluate the usefullness of disk diffusion method by using
different media for the susceptibility testing of fluconazole against Candida
albicans strains.
Methods: The susceptibility of 108 clinical isolates of C. albicans against
ftuconazole were determined by microdilution method and disk diffusion
method by using RPMI 1640 agar and 25 J.lg disks. 93 Ofthese isolates were
also tested by disk diffusion technique on four different media (yeast nitrogen
base agar (YNB), Sabouraud dextrose agar, Mueller Hinton agar and
Mueller Hinton methylene blue agar (MHMB). The results of the micro-
dilution method were evaluated visually and optically. The disk diffusion
results were determined after 24 and 48 hours ofincubation at 35°C.
Results: When the 24 hour zone diameters were compared to the minimal
inhibitory concentrations determined visually and optically, best results
were obtained for RPMI 1640 agar and YNB (The correlation coefficients
were r = -0.34, -0.41 and r = -0.33, -0.32 for the first and second
medium, respectively). The best values (r = -0.29, -0.39) were obtained
for MHMB when the 48 hour zone diameters were considered. The
agreement between the disk diffusion and microdilution methods were
determined to be the best for RPMI 1640 agar, YNB and MHMB aftef 24
hours of incubation (87-89%, 88-90%, 93-96%, respectively) and for
MHMB after 48 hours of incubation (89-96%).
Conclusions: Disk diffusion method using RPMI 1640, YNB and MHMB
appears to be an appliable, rapid and reliable screening technique for the
fluconazole susceptibility testing of C. albicans strains.
P:5/13 - Others
IWeP153!/n vitro susceptibility to antibiotics of Escherichia
coli isolates in community acquired urinary trad infections
z. Barisic, A. Babic-Erceg, E. Borzic, M. Cater, V. Kalitema, V. Zoranic,
M. SmoIjanovic
Public Health [tlstilllte, Split, Croatia
Objectives: To determine itl vitro susceptibility of E. coli isolates in com-
munity acquired urinary tract infections (CA-UTI) and to suggest optimal
empirical antibiotic therapy in these patients.
Methods: Three hundred fifthy seven consecutive stfainS of E. coli isolated
from patients with CA-UTI were included in this study. Isolation and
identification were performed by standard method and susceptibillity testing
was performed by disk diffusion method. Susceptibillity was tested to
amoxycillin (AMX), amoxycillin-clavulanate (AMC), cephalexin (CN),
cefuroxime (CXM), ceftibuten (CTB), trimethoprim-sulfamethoxazole
(STX) and ciprofloxacin (CIP).
Results: From total number of357 strains ofE. coli 44.32% were resistant to
AMX, 3.92% to AMC, 4.76% to CN, 2.24% to CXM, 0.84% to CTB,
17.ll9'Yu to STX and 1.77% strains were resistant to elP.
Conclusions: The best itl vitro susceptibillity was shown for ceftibuten,
followed by ciproftoxacin and cefuroxime. Strains of E. coli show high
resistance rate to trimethoprim-sulfamethoxazole and amoxycillin.
The antibiotic of the best choice for empirical antibiotic therapy in
patients with CA-UTI in our region is eeftibuten. Drugs like trimetha-
